Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 9.66 billion as of December 5, 2025. Its market cap has decreased by -30.30% in one year.

Market Cap

9.66B

Enterprise Value

8.13B

Revenue

37.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

78.80

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 9.66B, an increase of 8.98%. That is a compound annual growth rate of 0.98%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	9.66B	-32.76%
Dec 31, 2024	14.37B	-31.28%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	26.55B	222.07%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	258.22B
PharmaEssentia	191.95B
Lotus Pharmaceutical	78.89B
Bora Pharmaceuticals Co., LTD.	65.31B
Oneness Biotech	32.96B
Lumosa Therapeutics	32.77B
Lin BioScience	32.35B
Center Laboratories	27.88B

Market Cap Rankings